ペムブロリズマブの適応拡大に伴う副作用自発報告の変遷についての実態調査

Detailed bibliographic record

Summary, etc.：: <p>Pembrolizumab is an immune checkpoint inhibitor that has been widely used in cancer treatment, and its approved indications have expanded rapidly i...

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Material Type: 記事
Title: ペムブロリズマブの適応拡大に伴う副作用自発報告の変遷についての実態調査
Volume: 146
5
Author/Editor: 山本夏菜
酒井良子
赤沢学
Author Heading: 山本夏菜
Yamamoto Kana
酒井良子
Sakai Ryoko
赤沢学
Akazawa Manabu
Publication Date: 2026-05-01
Publication Date (W3CDTF): 2026-05-01
Alternative Title: Trends in Spontaneous Adverse Event Reports Following the Expansion of Pembrolizumab Indications in Japan
Periodical title: YAKUGAKU ZASSHI
No. or year of volume/issue: 146 5
Volume: 146
Issue: 5
Pages: 533-539
ISSN (Periodical Title): 0031-6903
1347-5231
Alias of Author: Yamamoto Kana
Sakai Ryoko
Akazawa Manabu
Subject Heading: pembrolizumab
immune-related adverse event
claims data
cancer type
endocrine toxicity
Target Audience: 一般
DOI: 10.1248/yakushi.25-00179
Access Restrictions: インターネット公開
Data Provider (Database): 科学技術振興機構 : J-STAGE
http://www.jstage.jst.go.jp